Podcasts · Pharma Market Access Insights - from Petauri Evidence
Artificial intelligence (AI) in clinical trials: Implications for evidence synthesis and market access
· 40 min · S5 E5
Episode Artificial intelligence (AI) in clinical trials: Implications for evidence synthesis and market access
Send us Fan Mail
How is Artificial Intelligence being used in the development of new medicines? What role can AI currently play in clinical trials? Where can AI bridge gaps and solve challenges? What could this mean for the future of market access? In this webinar, Dr George Magrath explains how his team at Lexitas are using AI in clinical trials in the field of ophthalmology. George and Calum explore: - How, when and where AI is being used in clinical trials - How Lexitas are using AI in clinical trials for ophthalmology - Where AI may offer solutions to existing obstacles in clinical trials and ophthalmic drug development - What the future holds for AI in the development of new medicines - The role AI can play in selecting patients for clinical trials - The impact AI may have on the way we evaluate drug effectiveness - What this all means for evidence synthesis, health economics, reimbursement and market access - The future prospects of AI in pharmaceutical development Learn more at: https://mtechaccess.co.uk/ai-clinical-trials-evidence/ This episode was first broadcast as a live webinar in August 2023.
Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence
Chapters
Transcript
Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them. Explicit shows are for adult profiles only, and children’s profiles hear only children’s shows. More about this list.